A detailed history of Savant Capital, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Savant Capital, LLC holds 100,652 shares of DXCM stock, worth $7.68 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
100,652
Previous 100,886 0.23%
Holding current value
$7.68 Million
Previous $11.4 Million 41.03%
% of portfolio
0.06%
Previous 0.11%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$64.0 - $116.06 $14,976 - $27,158
-234 Reduced 0.23%
100,652 $6.75 Million
Q2 2024

Aug 05, 2024

SELL
$110.31 - $140.45 $434,731 - $553,513
-3,941 Reduced 3.76%
100,886 $11.4 Million
Q1 2024

May 03, 2024

SELL
$114.22 - $140.1 $261,906 - $321,249
-2,293 Reduced 2.14%
104,827 $14.5 Million
Q4 2023

Feb 05, 2024

SELL
$75.49 - $124.16 $297,506 - $489,314
-3,941 Reduced 3.55%
107,120 $13.3 Million
Q3 2023

Nov 06, 2023

SELL
$86.06 - $137.93 $71,515 - $114,619
-831 Reduced 0.74%
111,061 $10.4 Million
Q2 2023

Aug 04, 2023

SELL
$112.47 - $130.98 $145,086 - $168,964
-1,290 Reduced 1.14%
111,892 $14.4 Million
Q1 2023

May 02, 2023

SELL
$104.0 - $122.92 $520 - $614
-5 Reduced -0.0%
113,182 $13.1 Million
Q4 2022

Feb 06, 2023

SELL
$84.98 - $122.67 $8,922 - $12,880
-105 Reduced 0.09%
113,187 $12.8 Million
Q3 2022

Oct 28, 2022

SELL
$76.35 - $94.18 $12,368 - $15,257
-162 Reduced 0.14%
113,292 $9.13 Million
Q2 2022

Jul 22, 2022

BUY
$67.99 - $132.89 $5.78 Million - $11.3 Million
85,026 Added 299.09%
113,454 $8.46 Million
Q1 2022

May 05, 2022

SELL
$94.08 - $130.2 $18,251 - $25,258
-194 Reduced 0.68%
28,428 $14.5 Million
Q4 2021

Feb 08, 2022

SELL
$129.87 - $162.82 $48,571 - $60,894
-374 Reduced 1.29%
28,622 $15.4 Million
Q3 2021

Nov 12, 2021

SELL
$106.71 - $143.18 $117,914 - $158,213
-1,105 Reduced 3.67%
28,996 $15.9 Million
Q2 2021

Aug 04, 2021

BUY
$80.99 - $107.93 $485 - $647
6 Added 0.02%
30,101 $12.9 Million
Q1 2021

May 04, 2021

SELL
$84.79 - $104.74 $508 - $628
-6 Reduced 0.02%
30,095 $10.8 Million
Q4 2020

Feb 03, 2021

SELL
$78.0 - $104.5 $51,168 - $68,552
-656 Reduced 2.13%
30,101 $11.1 Million
Q3 2020

Nov 04, 2020

BUY
$95.51 - $112.95 $1,337 - $1,581
14 Added 0.05%
30,757 $12.7 Million
Q2 2020

Aug 11, 2020

BUY
$62.68 - $105.34 $313 - $526
5 Added 0.02%
30,743 $12.5 Million
Q1 2020

Apr 30, 2020

SELL
$47.79 - $75.63 $3,918 - $6,201
-82 Reduced 0.27%
30,738 $8.28 Million
Q4 2019

Jan 31, 2020

SELL
$36.62 - $57.29 $33,434 - $52,305
-913 Reduced 2.88%
30,820 $6.74 Million
Q3 2019

Nov 12, 2019

BUY
$35.53 - $43.8 $1,456 - $1,795
41 Added 0.13%
31,733 $4.74 Million
Q2 2019

Aug 06, 2019

BUY
$27.84 - $38.92 $584 - $817
21 Added 0.07%
31,692 $4.75 Million
Q1 2019

May 02, 2019

SELL
$28.07 - $38.18 $4,996 - $6,796
-178 Reduced 0.56%
31,671 $3.77 Million
Q4 2018

Feb 05, 2019

SELL
$26.99 - $37.37 $150,172 - $207,926
-5,564 Reduced 14.87%
31,849 $3.82 Million
Q2 2018

Aug 07, 2018

SELL
$17.54 - $25.22 $3,367 - $4,842
-192 Reduced 0.51%
37,413 $3.55 Million
Q1 2018

Apr 27, 2018

SELL
$13.06 - $18.54 $34,844 - $49,464
-2,668 Reduced 6.62%
37,605 $2.79 Million
Q4 2017

Jan 31, 2018

SELL
$11.12 - $15.38 $5,471 - $7,566
-492 Reduced 1.21%
40,273 $2.31 Million
Q3 2017

Oct 31, 2017

BUY
$11.36 - $18.98 $463,090 - $773,719
40,765
40,765 $1.99 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $29.5B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Savant Capital, LLC Portfolio

Follow Savant Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Savant Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Savant Capital, LLC with notifications on news.